Papillary thyroid cancer other diagnostic studies: Difference between revisions

	Papillary thyroid cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Papillary thyroid cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Papillary thyroid cancer other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Papillary thyroid cancer other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Papillary thyroid cancer other diagnostic studies
CDC on Papillary thyroid cancer other diagnostic studies
Papillary thyroid cancer other diagnostic studies in the news
Blogs on Papillary thyroid cancer other diagnostic studies
Directions to Hospitals Treating Papillary thyroid cancer
Risk calculators and risk factors for Papillary thyroid cancer other diagnostic studies

VisualWikitext

Latest revision as of 23:34, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

There are no other diagnostic studies associated with papillary thyroid cancer.

Other Diagnostic Studies

There are no other diagnostic studies associated with papillary thyroid cancer.

Template:WikiDoc Sources

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{Ammu}}
 ==Overview==
-Other diagnostic studies for papillary thyroid cancer include mRNA measurement, which demonstrates residual metastatic disease.
+There are no other [[diagnostic]] studies associated with papillary thyroid cancer.
-==Key Findings in mRNA in Papillary thyroid cancer==
+==Other Diagnostic Studies==
-* Chia et al. report that TSHR mRNA measured with FNA enhances the preoperative detection of cancer in patients with thyroid nodules, reducing unnecessary surgeries, and immediate postoperative levels can predict residual/metastatic disease. Suspected lung metastases and/or miliary aspects at x-ray or CT can be diagnosed by cytology on a [[bronchoalveolar lavage]] specimen.<ref name=Vermeer-Mens2006>{{Cite journal | last1 = Vermeer-Mens | first1 = J. C. J. | last2 = Goemaere | first2 = N. N. T. | last3 = Kuenen-Boumeester | first3 = V. | last4 = De Muinck Keizer-Schrama | first4 = S. M. P. F. | last5 = Zwaan | first5 = C. M. | last6 = Devos | first6 = A. S. | last7 = De Krijger | first7 = R. R. | doi = 10.1200/JCO.2006.08.8732 | title = Childhood Papillary Thyroid Carcinoma with Miliary Pulmonary Metastases | journal = Journal of Clinical Oncology | volume = 24 | issue = 36 | pages = 5788–5789 | year = 2006 | pmid = 17179115}} [http://jco.ascopubs.org/content/24/36/5788.full.pdf]</ref>
+* There are no other [[diagnostic]] studies associated with papillary thyroid cancer.
-==References==
+{{WikiDoc Help Menu}}
-{{Reflist|2}}
+{{WikiDoc Sources}}
 [[Category:Endocrine system]]
@@ Line 17: / Line 17: @@
 [[Category:Hereditary cancers]]
 [[Category:Thyroid disease]]
-[[Category:Primary care]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}

Papillary thyroid cancer other diagnostic studies: Difference between revisions

Latest revision as of 23:34, 29 July 2020

Overview

Other Diagnostic Studies

Navigation menu